stockrow
Friday 6 November 2026
Export ELUT’s income statement to Excel — free account
Elutia Inc.
ELUT Healthcare Medical Devices
Elutia Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.3 million, down 15.0% from fiscal 2024.
- Revenue
- −11.7%
- EPS
- +26.1%
- Free cash flow
- −2.52%
Quarter to June 2026, against a year earlier
0.85
0.10
+13.33%
Follow ELUT
Alert me
Elutia Inc. (ELUT) P/E ratio
As of 5 November 2026, Elutia Inc. (ELUT) trades at a P/E ratio of 0.6×. Over the past ten years it has ranged from 0.0× (December 2025) to 1.0× (May 2026); the current reading is higher than 87% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.6× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.8× | (11.22%) |
| Mar 2026 | 0.9× | 61.26% |
| Dec 2025 | 0.6× | — |
| Sep 2025 | 0.0× | — |
| 22 more quarters | Free account |
Against its own ten years
Low 0.0×
High 1.0×
Ten-year median
0.0×
Current reading's percentile
87
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TELA TELA Bio, Inc. compare | n/m |
| CVRX CVRx, Inc. compare | n/m |
| RPID Rapid Micro Biosystems, Inc. compare | n/m |
| QTI QT Imaging Holdings, Inc. compare | n/m |
| NNOX Nano-X Imaging Ltd. compare | n/m |
| NSPR InspireMD, Inc. compare | n/m |
| XTNT Xtant Medical Holdings, Inc. compare | n/m |
| ELUT Elutia Inc. | 0.6× |
| NSYS Nortech Systems Incorporated compare | 28.4× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)